Details of the Drug

General Information of Drug (ID: DMQHZE9)

Drug Name
Tacalcitol
Synonyms Bonalfa (TN)
Indication
Disease Entry ICD 11 Status REF
Psoriasis vulgaris EA90 Approved [1]
ATC Code
D05AX04: Tacalcitol
D05AX: Other antipsoriatics for topical use
D05A: ANTIPSORIATICS FOR TOPICAL USE
D05: ANTIPSORIATICS
D: DERMATOLOGICALS
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C27H44O3
Canonical SMILES
CC(C)C(CCC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C)O
InChI
InChI=1S/C27H44O3/c1-17(2)25(29)13-8-18(3)23-11-12-24-20(7-6-14-27(23,24)5)9-10-21-15-22(28)16-26(30)19(21)4/h9-10,17-18,22-26,28-30H,4,6-8,11-16H2,1-3,5H3/b20-9+,21-10-/t18-,22-,23-,24+,25-,26+,27-/m1/s1
InChIKey
BJYLYJCXYAMOFT-RSFVBTMBSA-N
Cross-matching ID
PubChem CID
5283734
ChEBI ID
CHEMBL32176
CAS Number
57333-96-7
UNII
C2W72OJ5ZU
DrugBank ID
DB13689
TTD ID
D08SVH
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Drug Pharmacogenomic Perturbation (DPP)NEW Click to Jump to the Detailed DPP Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2780).